Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
AbbVie, Inc.

2. Address

Address1
1399 New York Avenue NW
 Address2
​Suite 600
City
Washington
 State
DC
 Zip Code
20005
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Mr.
​Paul Ehrlich
​2023839669
​paul.ehrlich@abbvie.com
5. Senate ID#
​401049961-12
7. Client Name Self Check if client is a state or local government or instrumentality
​AbbVie, Inc.
6. House ID#
​422720000
TYPE OF REPORT 8. Year
​2015
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​930,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Paul Ehrlich
 Date
10/19/2015 4:01:54 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

H.R.2029, Military Construction and Veterans Affairs and Related Agencies Appropriations Act;
Other Labor, Health and Human Services Appropriations (No Bills Introduced);
H.R. 1078, Food & Drug Administration Safety Over Sequestration Act;
S. 1413, FDA User Fee Protection Act;
FDAs Changes Being Effected Rule;

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Catherine
Ferguson
​
​
John
Ford
​
​
Andrew
Kaplan
​
​
Heather
Strawn
​
​
Stephen
Scango
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

H.R. 3116, MODDERN Cures Act of 2013;
S. 632, STRONG Patents Act of 2015;
H.R. 9, Innovation Act;
H.R. 160, Protect Medical Innovation Act of 2015;
H.R. 971 & S. 1421, Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015;
S. 1137, Protecting American Talent and Entrepreneurship Act of 2015;
Proposals/Initiatives related to international intellectual property protection;

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR), Patent & Trademark Office (PTO), Health & Human Services - Dept of (HHS), State - Dept of (DOS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
John
Ford
​
​
Andrew
Kaplan
​
​
Heather
Strawn
​
​
Catherine
Ferguson
​
​
Michael
Boyd
​
​
Stephen
Scango
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

H.R. 6, 21st Century Cures Act;
Discussions to clarify or reform the 340B program;
Biologics Price Competition and Innovation Act;
H.R. 2031, TEST Act;
H.R. 1101 & S. 1287, Viral Hepatitis Testing Act;
Proposals to improve viral hepatitis screening and testing;
Public Law 111-148, The Patient Protection and Affordable Care Act;
Public Law 111-152, The Health Care and Education Reconciliation Act;
Implementation of The Prescription Drug User Fee Act (PDUFA);
H.R. 2570 & S. 1396, Value-Based Insurance Design Seniors Copayment Reduction Act of 2015; Proposals to address chronic care coordination;
Discussions on international health policy including World Health Organization resolutions;

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Michael
Boyd
​
​
Catherine
Ferguson
​
​
John
Ford
​
​
Andrew
Kaplan
​
​
Heather
Strawn
​
​
Stephen
Scango
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Policies to enhance patient access to medicines in Medicaid;
Policies to enhance patient access to medicines in Medicare;
H.R. 2298, Medicare Patient Safety and Drug Abuse Prevention Act;
H.R. 2914, Promoting Integrity in Medicare Act;
S. 141, Protecting Seniors' Access to Medicare Act of 2015
H.R. 2925, Strengthening Medicare Anti-Fraud Measures Act;
S. 31, Medicare Prescription Drug Price Negotiation Act of 2015;
H.R. 1102 & S. 117, Medicare Prescription Drug Price Negotiation Act;
H.R. 2005 & S. 1083, Medicare Drug Savings Act;

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
John
Ford
​
​
Andrew
Kaplan
​
​
Heather
Strawn
​
​
Stephen
Scango
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

H.R. 880, American Research and Competitiveness Act of 2015;
H.R. 1430, Permanent CFC Look-Through Act;
Administrations Tax Reform and 2015 Budget Proposals;
Senate and House Committee Tax Reform Proposals;
Proposals to reform domestic and international tax structures (no bills introduced);

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Michael
Boyd
​
​
Andrew
Kaplan
​
​
Heather
Strawn
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TRD

16. Specific lobbying issues

Trans-Atlantic Trade and Investment Partnership;
Trans-Pacific Partnership Agreement;
Trade Promotion Authority;
H.R. 1890 & S. 995, Bipartisan Congressional Trade Priorities and Accountability Act of 2015;
Middle East Trade Issues;

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR), Patent & Trademark Office (PTO)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Catherine
Ferguson
​
​
Andrew
Kaplan
​
​
Heather
Strawn
​
​
Michael
Boyd
​
​
John
Ford
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6